Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating ulcerative colitis and preparation method therefor

A technology for ulcerative colitis and medicine, which is applied in the field of medicine, can solve the problems of large side effects and poor curative effect, and achieve the effect of small side effects, scientific selection of materials, and high safety

Inactive Publication Date: 2021-02-09
赵亮亮
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The purpose of the present invention is to provide a medicine for treating ulcerative colitis and its preparation method, so as to alleviate the technical problems of poor curative effect and large side effects in the medicine in the prior art; the present invention provides a medicine with high safety and good curative effect Drugs for the treatment of ulcerative colitis with few side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0073] A medicine for treating ulcerative colitis. The raw materials of the medicine are proportioned by weight: 25-35 parts of decanoyl acetaldehyde, 15-20 parts of baicalin, 5-10 parts of limonin, and sulfasalazine 5-10 parts, balsalazide sodium 1-3 parts, mesalazine 1-3 parts, metronidazole 1-3 parts.

[0074] A preparation method of a medicine for treating ulcerative colitis, the preparation method comprising the following steps:

[0075] S1. Weigh high-quality decanoyl acetaldehyde, baicalin, sulfasalazine, limonin, sodium balsalazide, mesalazine, and metronidazole by parts by weight, and set aside;

[0076] S2. Put decanoyl acetaldehyde, baicalin, sulfasalazine, limonin, balsalazide sodium, mesalazine, and metronidazole in a three-dimensional mixer and mix evenly to obtain the total blend, which is the A drug for the treatment of ulcerative colitis.

[0077] The medicine for treating ulcerative colitis also includes medically acceptable auxiliary materials, the mass ra...

Embodiment 2

[0083] Said medicine for treating ulcerative colitis, each component in the raw material of the medicine is according to the preferred weight ratio: 35 parts of decanoyl acetaldehyde, 20 parts of baicalin, 10 parts of limonin, 10 parts of sulfasalazine , balsalazide sodium 3 parts, mesalazine 3 parts, metronidazole 3 parts.

[0084] A preparation method of a medicine for treating ulcerative colitis, the preparation method comprising the following steps:

[0085] S1. Weigh high-quality decanoyl acetaldehyde, baicalin, sulfasalazine, limonin, sodium balsalazide, mesalazine, and metronidazole by parts by weight, and set aside;

[0086] S2. Put decanoyl acetaldehyde, baicalin, sulfasalazine, limonin, balsalazide sodium, mesalazine, and metronidazole in a three-dimensional mixer and mix evenly to obtain the total blend, which is the A drug for the treatment of ulcerative colitis.

[0087] The medicine for treating ulcerative colitis also includes a medically acceptable auxiliary ...

Embodiment 3

[0093] Said medicine for treating ulcerative colitis, each component in the raw material of the medicine is according to the preferred weight ratio: 30 parts of decanoyl acetaldehyde, 17.5 parts of baicalin, 7.5 parts of limonin, and 7.5 parts of sulfasalazine , balsalazide sodium 2 parts, mesalazine 2 parts, metronidazole 2 parts.

[0094] A preparation method of a medicine for treating ulcerative colitis, the preparation method comprising the following steps:

[0095] S1. Weigh high-quality decanoyl acetaldehyde, baicalin, sulfasalazine, limonin, sodium balsalazide, mesalazine, and metronidazole by parts by weight, and set aside;

[0096] S2. Put decanoyl acetaldehyde, baicalin, sulfasalazine, limonin, balsalazide sodium, mesalazine, and metronidazole in a three-dimensional mixer and mix evenly to obtain the total blend, which is the A drug for the treatment of ulcerative colitis.

[0097] The medicine for treating ulcerative colitis also includes medically acceptable auxi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of medicines and particularly relates to a medicine for treating ulcerative colitis and a preparation method therefor. The medicine for treating the ulcerative colitis, provided by the invention, comprises the ingredients in parts by weight: 25-35 parts of decanoyl acetaldehyde, 15-20 parts of baicalin, 5-10 parts of limonin, 5-10 parts of salazosulfapyridine, 1-3 parts of Balsalazide disodium, 1-3 parts of Mesalazine and 1-3 parts of metronidazole. The medicine for treating the ulcerative colitis, provided by the invention, is high in safety, goodin treatment effect and low in side effect. The preparation method for the medicine for treating the ulcerative colitis, provided by the invention, is scientific in sorting, reasonable in blending andadvanced in process and is applicable to mass production.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a medicine for treating ulcerative colitis and a preparation method thereof. Background technique [0002] Ulcerative colitis is a digestive tract disease characterized by chronic inflammation of the colonic mucosa and ulcer formation as the main symptoms, such as diarrhea, mucus pus and blood in the stool, abdominal pain, and tenesmus. The incidence rate of this disease is relatively high in the developed regions of Europe and America, about 18 per 100,000, while in Asia, especially Japan, its incidence rate increased rapidly after the 1970s with the recovery of the economy. 15 times more history. [0003] In my country, in recent years, due to the continuous improvement of living standards, changes in diet structure and living habits, and the improvement of inspection and diagnosis techniques, the incidence rate has also shown an upward trend year by year. Because the diseas...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/185A61K31/7048A61K31/585A61K31/196A61K31/4164A61K31/44A61K31/655A61P1/04
CPCA61K31/185A61K31/196A61K31/4164A61K31/44A61K31/585A61K31/655A61K31/7048A61P1/04A61K2300/00
Inventor 赵亮亮
Owner 赵亮亮
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com